"The executive order directs the administration to promptly evaluate and possibly approve psychedelics for medical purposes, which could also make it easier for researchers to study these substances."
"Some early research suggests that ibogaine could help treat depression and substance use disorders in some people, but it has been shown to have serious side effects."
"An estimated 15.4 million adults in the U.S. live with severe mental illness, according to the National Institutes of Health."
"Veterans are at particular risk: Research shows that suicide rates are nearly twice as high among veterans as they are in the general population."
President Trump's executive order seeks to expedite research on psychedelics like MDMA, psilocybin, LSD, and ibogaine for potential medical use. The order directs the administration to evaluate and possibly approve these substances, facilitating research efforts. It allocates $50 million for state-level psychedelic research, particularly on ibogaine, which shows promise in treating depression and substance use disorders despite serious side effects. With 15.4 million adults in the U.S. suffering from severe mental illness, this initiative could provide alternative treatment options.
Read at www.scientificamerican.com
Unable to calculate read time
Collection
[
|
...
]